Stock comparison
Merck & Co., Inc. is 213.0x more valuable than GH Research PLC by market capitalization ($367.16 B vs $1.72 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 213.0x more valuable than GH Research PLC by market capitalization ($367.16 B vs $1.72 B).
Market value leader
MRK
Merck & Co., Inc. is 213.0x more valuable than GH Research PLC by market capitalization ($367.16 B vs $1.72 B).
| Metric | GHRS | MRK |
|---|---|---|
| Market cap | $1.72 B | $367.16 B |
| US-listed rank | #2254 | #35 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 20.1x |
| SEC filings | 186 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 213.0x more valuable than GH Research PLC by market capitalization ($367.16 B vs $1.72 B).
Full pages: GH Research PLC and Merck & Co., Inc., or browse the full rankings.